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Research
Over the past decades, numerous epidemio-
logic studies have shown an association of 
cardio  vascular disease (CVD) with particulate 
air pollution exposures (Laden et al. 2006; 
Puett et al. 2008). Possible biologic path-
ways for this association include alterations 
in cardiac autonomic function, the release 
of circulating prooxidative and proinflam-
matory mediators from the lungs into the 
systemic circulation after particle inhala-
tion, and translocation of ultrafine particles 
and soluble constituents of particles into 
the systemic circulation (Brook 2008). The 
pathway by which exposure to particulate 
pollutants adversely affects the cardiac auto-
nomic nervous system may, in part, account 
for an increased risk of arrhythmias and 
sudden cardiac death associated with par-
ticulate exposure. In recent experimental 
studies, scientists prevented particle-induced 
cardiac oxidative stress by pretreating rats 
with autonomic nerve receptor antagonists 
(Rhoden et al. 2005) and particle-induced 
neuro  plasticity of cardiac vagal neurons   
(Pham et al. 2009). The results of these 
studies have suggested that cardiac particle 
toxicity is mediated by autonomic nervous 
system stimulation.
Numerous epidemiologic studies have 
shown an association between particulate air 
pollution and cardiac autonomic dysfunction, 
as measured by heart rate variability (HRV) 
(Chuanget al. 2007; Holguin et al. 2003; 
Liao et al. 2004; Park et al. 2005; Whitsel 
et al. 2009). However, most previous studies 
have used a small number of subjects; only 
a few studies have been conducted in popu-
lation-based cohorts (Liao et al. 2004; Park 
et al. 2005; Whitsel et al. 2009). Only one 
study (Park et al. 2005) examined an associa-
tion with particulate matter (PM) ≤ 2.5 µm 
in aerodynamic diameter (PM2.5). Churg and 
Brauer (2000) have suggested that PM2.5 is 
more harmful to health than are larger par-
ticles [which are included in measurements 
of PM ≤ 10 µm in aerodynamic diameter 
(PM10)] because PM2.5 can penetrate deeper 
into the lung than PM10.
Some studies have found that associa-
tions between PM exposure and autonomic 
dysfunction are stronger among persons with 
type 2 diabetes (Park et al. 2005; Whitsel et al. 
2009), hypertension (Holguin et al. 2003; 
Park et al. 2005), and obesity (Chen et al. 
2007; Schwartz et al. 2005). The findings from 
these studies indicate that preexisting cardio-
metabolic diseases may confer susceptibility 
to cardiac autonomic dysfunction by particle 
exposure. Metabolic syndrome (MetS), a clus-
ter of health risks characterized by abdomi-
nal obesity, type 2 diabetes, hypertension, and 
dyslipidemia (Moller and Kaufman 2005), 
has been associated with increased activity 
of the sympathetic nervous system, as have 
the individual conditions that define MetS 
(Tentolouris et al. 2008). In a recent study 
from Korea, Min et al. (2009) observed a sig-
nificant reduction in HRV related to exposure 
to carbon monoxide (CO) among persons with 
MetS but not among persons without MetS 
(Min et al. 2009). Because of the increasing 
prevalence of MetS and its association with 
an increased risk of CVD, it is important to 
determine whether MetS or its individual 
components may increase susceptibility to the 
cardio  vascular effects of air pollution.
We used data from the Multi-Ethnic Study 
of Atherosclerosis (MESA), a large population-
based study, to investigate associations between 
HRV and PM2.5 and to assess potential effect 
modification by MetS and its components.
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Ba c k g r o u n d: Cardiac autonomic dysfunction has been suggested as a possible biologic pathway 
for the association between fine particulate matter ≤ 2.5 µm in diameter (PM2.5) and cardiovascular 
disease (CVD). We examined the associations of PM2.5 with heart rate variability, a marker of auto-
nomic function, and whether metabolic syndrome (MetS) modified these associations.
Me t h o d s : We used data from the Multi-Ethnic Study of Atherosclerosis to measure the standard 
deviation of normal-to-normal intervals (SDNN) and the root mean square of successive differences 
(rMSSD) of 5,465 participants 45–84 years old who were free of CVD at the baseline examination 
(2000–2002). Data from the U.S. regulatory monitor network were used to estimate ambient PM2.5 
concentrations at the participants’ residences. MetS was defined as having three or more of the fol-
lowing criteria: abdominal obesity, hypertriglyceridemia, low high-density lipoprotein cholesterol, 
high blood pressure, and high fasting glucose.
re s u l t s: After controlling for confounders, we found that an interquartile range (IQR) increase in 
2-day average PM2.5 (10.2 µg/m3) was associated with a 2.1% decrease in rMSSD [95% confidence 
interval (CI), –4.2 to 0.0] and nonsignificantly associated with a 1.8% decrease in SDNN (95% CI, 
–3.7 to 0.1). Associations were stronger among individuals with MetS than among those without 
MetS: an IQR elevation in 2-day PM2.5 was associated with a 6.2% decrease in rMSSD (95% CI, 
–9.4 to –2.9) among participants with MetS, whereas almost no change was found among par-
ticipants without MetS (p-interaction = 0.005). Similar effect modification was observed in SDNN 
(p-interaction = 0.011).
co n c l u s i o n: These findings suggest that autonomic dysfunction may be a mechanism through 
which PM exposure affects cardiovascular risk, especially among persons with MetS.
key w o r d s : air pollution, autonomic nervous system, heart rate variability, metabolic syndrome, 
PM2.5. Environ Health Perspect 118:1406–1411 (2010).  doi:10.1289/ehp.0901778 [Online 
8 June 2010]PM2.5, metabolic syndrome, and HRV
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Materials and Methods
Study population. The MESA is a longitudinal 
study supported by the National Heart, Lung, 
and Blood Institute; its aim is to identify risk 
factors for subclinical atherosclerosis. A total of 
6,814 participants 45–84 years old who were 
free of clinically apparent CVD at the base-
line examination were recruited from six U.S. 
communities: Baltimore City and Baltimore 
County, Maryland; Chicago, Illinois; Forsyth 
County, North Carolina; Los Angeles County, 
California; northern Manhattan and the 
Bronx, New York; and St. Paul, Minnesota. 
Details of the study design are described else-
where (Bild et al. 2002). Our study used data 
from the baseline visit that occurred between 
July 2000 and August 2002. Of the 6,814 par-
ticipants who completed the baseline clinical 
examination, a total of 1,349 were excluded 
from the study because of non  participation 
in the air pollution study (n = 618), miss-
ing or poor quality electrocardiogram (ECG) 
data (n = 401), missing information on PM2.5 
exposure (n = 160), missing information on 
both ECG and PM2.5 (n = 65), or missing 
information on temperature (n = 11) and 
other covariates (n = 94). Therefore, 5,465 
participants with complete data were available 
for the analyses. Compared with other par-
ticipants, those who were excluded (n = 1,349) 
were older (65 years old vs. 62 years old), 
more likely to be African American (33% vs. 
27%) and current smokers (16% vs. 12%), 
more likely to be from Baltimore (21% vs. 
15%) and less likely to be from Chicago (13% 
vs. 18%), and at higher risk of hypertension 
(22% vs. 18%) and type 2 diabetes (25% vs. 
19%). The study protocol was approved by the 
institutional review board at each study site, 
and written informed consent was obtained 
from each participant.
Air pollution and meteorologic data. Air 
pollutant data were extracted from the U.S. 
Environmental Protection Agency (EPA) 
Aerometric Information Retrieval System 
(U.S. EPA 2007). PM2.5 concentrations were 
obtained from 24-hr integrated samplers, 
which collected data daily or every third day. 
For each participant, we obtained PM2.5 con-
centration data for the 60 days before the day 
on which HRV measures were obtained. Each 
daily exposure measure was obtained from 
the moni  tor nearest to the participant’s resi-
dence with available data for a given day. We 
constructed five exposure measures: PM2.5 
concentration the day before HRV measure-
ment, and average PM2.5 concentrations 
over the 2, 7, 30, and 60 days prior to HRV   
meas  ure  ment. Gaseous pollutants [sulfur diox-
ide (SO2), nitrogen dioxide (NO2), and CO] 
were also included. Ozone was not analyzed 
because of incomplete information in the win-
ter. Meteorologic data including temperature 
and dew point temperature were obtained 
from the National Climatic Data Center 
(NCDC 2008). To control for weather, we 
used apparent temperature, defined as a per-
son’s perceived air temperature, which com-
bines the effects of heat and humidity in one 
variable (O’Neill et al. 2003).
HRV measurement. After at least a 5-min 
rest, three consecutive 10-sec recordings of 
simultaneous 12-lead ECGs (Marquette   
MAC-1200; GE Healthcare, Milwaukee, WI, 
USA) were measured and read electronically 
after transmission over analog phone lines 
to a central ECG reading center that was 
blinded to all clinical and personal details of 
the participants. Most (92%) of the ECGs 
were assessed in the morning. ECG abnor-
malities were identified by a program using 
Nova code criteria (Rautaharju et al. 1998) 
and Minnesota code criteria (Prineas et al. 
1982). On ECGs with > 50% normal-to-
normal (NN) interbeat intervals, two ECG 
measures of HRV were calculated using three 
consecutive 10-sec recordings: the standard 
deviation of NN intervals (SDNN) and the 
root mean square of successive differences of 
NN intervals (rMSSD). In general, SDNN 
and rMSSD measures based on ultrashort 
(e.g., 10 sec) recordings indicate short-term, 
resting parasympathetic (respiratory) varia-
tion. We excluded participants who had only 
one 10-sec HRV measure (1%); averages of 
two (7%) or three (92%) 10-sec HRV meas-
ures were computed and included in the 
statistical analysis. The validity of the HRV 
calculation method was verified by senior 
electro  cardiographers and a biostatistician 
using a test data set of 264 ECGs. Prior work 
has shown high correlations between 10-sec 
and 6-min measures: correlation coefficients 
[95% confidence intervals (CIs)] 0.76 (0.68–
0.82) for SDNN and 0.82 (0.75–0.86) for 
rMSSD (Schroeder et al. 2004).
MetS and individual metabolic abnor-
malities. We used the criteria of the National 
Cholesterol Education Program Adult 
Treatment Panel III (Moller and Kaufman 
2005) and defined persons with three 
or more of the following criteria as hav-
ing MetS: a) abdominal obesity (waist cir-
cumference > 102 cm in men or > 88 cm 
in women); b) hypertriglyceridemia (≥ 150   
mg/dL); c) low high-density lipoprotein 
(HDL) cholesterol (< 40 mg/dL in men 
or < 50 mg/dL in women); d) high blood 
pressure (≥ 130/85 mm Hg or use of anti-
hypertensive medication); and e) impaired 
fasting glucose (≥ 110 mg/dL, or self-
reported diabetes or use of diabetes medi-
cation). We used clinical cutoff points for 
each of the individual components of 
MetS rather than the criteria used in MetS 
above to maintain a high degree of specific-
ity for each disease. Diabetes was defined 
as fasting blood glucose of ≥ 126 mg/dL   
and/or use of diabetes medication (insulin or 
oral hypoglycemic agents). Hypertension was 
defined as blood pressure ≥ 140/90 mm Hg or 
use of hypertension medication. Dyslipidemia 
was defined as having both hypertriglyceri-
demia and low HDL cholesterol.
Statistical analysis. Linear regression 
analyses were used to test for the associations 
between HRV measures and PM2.5. HRV 
measures were log transformed to normal-
ize and to stabilize the variance. The follow-
ing potential confounding variables were 
selected a priori and included in the model 
regardless of statistical significance: age, sex,   
race/ethnicity, cigarette smoking, body mass 
index (BMI), fasting blood glucose, mean 
arterial pressure, use of cardiac medications 
(beta blockers, angiotensin-converting enzyme 
inhibitors, and calcium channel blockers), and 
the lagged moving average of apparent tem-
perature corresponding to the same moving 
average period for PM2.5. Categorical variables 
were modeled as shown in Table 1. We used 
beta blockers, angiotensin-converting enzyme 
inhibitors and calcium channel blockers as 
classes of anti  hypertensive medications to 
make our models comparable with the models 
used in Park et al. (2005). The results did not 
change when we used an indicator variable 
for all possible antihypertensive medications, 
including diuretics and angiotensin II recep-
tor antagonists. We also considered education, 
alcohol consumption, physical activity, serum 
total cholesterol, serum triglyceride, and use 
of statins in our models, but only serum tri-
glyceride was included in final models, as it 
was the only one that changed the beta coeffi-
cients of PM2.5 by > 10%. To account for the 
nonlinear association of apparent temperature 
with HRV, we used a regression spline with 
3 degrees of freedom (df). Season may be an 
important confounder, because both PM2.5 
concentrations and HRV show seasonal varia-
tions. In MESA, seasons vary by study sites; 
for example, winter in Los Angeles is different 
from winter in Chicago or New York. To 
control for seasonality at different study sites, 
we added interaction terms between splines of 
apparent temperature (3 df) and study sites. 
This model captures site-specific seasonality.   
We also created an indicator variable of warm 
months by study sites. Warm months were 
defined as those in which the average monthly 
temperature was greater > 10°C (50°F). 
For Baltimore, Forsyth County, and New 
York, warm months occurred from April 
to October. For Chicago and St. Paul, they 
occurred from May to October. Los Angeles 
has warm months all year long. We added 
this indicator variable to the model to remove 
any residual confounding by season. We also 
examined possible confounding effects of gas-
eous pollutants (SO2, NO2, and CO) and 
their independent associations with HRV.Park et al.
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We checked for possible nonlinear rela-
tions between HRV and other continuous 
covariates using penalized splines, but there 
was no evidence of strong nonlinear relations; 
thus, we fit all other continuous covariates 
as linear terms. We present effect estimates 
as percent change for an interquartile range 
(IQR) increase for PM2.5. We checked 
whether the relation between PM2.5 and HRV 
was linear by fitting PM2.5 as a smoothing 
term using penalized splines. This smoothing 
method makes no assumptions regarding the 
shape of the association (Wood 2006), and the 
penalized splines can be estimated in a gener-
alized additive model using R (version 2.9.2; 
The R Foundation for Statistical Computing, 
Boston, MA).
Study site may be an important confounder 
or an effect modifier, because the composition 
of PM2.5 may vary by different locations. Two 
analytical approaches were used to account for 
site: one was to additionally adjust for study 
site in the regression model as described above, 
and the other was to construct site-specific 
regression models and pool the estimates using 
meta-analysis. Heterogeneity of effect estimates 
was assessed with a χ2 test with 5 df. If hetero-
geneity by study sites was found, random-effect 
models were used to obtain a pooled estimate 
while accounting for site heterogeneity.
To assess effect modification by MetS 
and its individual components, multiplicative 
interaction terms along with the main effects 
were included in regression models. We also 
examined effect modification by other individ-
ual-level factors, including sex, education, ciga-
rette smoking, cardiac medication, and use of   
statins. The p-value of significance was < 0.05.
Results
Table 1 shows the distribution of demographic 
and clinical characteristics of the study par-
ticipants. The average age of participants was 
62 years, and approximately half of the partici-
pants were female. The prevalence of hyper-
tension, type 2 diabetes, abdominal obesity, 
dyslipidemia, and MetS was 43%, 12%, 54%, 
19%, and 32%, respectively. Persons with 
MetS were older, more likely to be women, 
and to have had lower HRV measures. Two 
days before the HRV measurement, PM2.5 
concentrations averaged from 10.3 µg/m3 in 
St. Paul to 19.3 µg/m3 in Los Angeles, with 
an overall mean of 14.3 µg/m3. Overall, the 
correlations between PM2.5 and the corre-
sponding moving averages of apparent tem-
perature were modest (Spearman correlation 
coefficients between 0.21 and 0.31). Month 
averages of PM2.5 concentrations (30-day and 
60-day means for PM2.5) were moderately cor-
related with shorter-term averages (prior day 
and 2-day mean PM2.5) (Spearman correlation 
coefficients 0.35 to 0.48).
Table 2 shows adjusted geometric means 
and geometric standard errors of HRV measures 
for sex, race/ethnicity, and study sites, stratified 
by MetS. In general, persons with MetS had 
lower HRV values than those without MetS. 
Women and African Americans had higher 
HRV measures than men and other race/ethnic 
groups, respectively. HRV measures differed 
by the study sites. For persons without MetS, 
HRV measures were lower in Baltimore and 
Chicago and higher in Forsyth County, Los 
Angeles, and St. Paul. For persons with MetS, 
Baltimore and Forsyth County had higher val-
ues, whereas Los Angeles had the lowest values. 
The differences in HRV values between persons 
with and without MetS were greatest in Los 
Angeles, and no differences in MetS status were 
observed among participants in Baltimore.
Table 3 presents adjusted associations of 
HRV measures with various lags of PM2.5. All 
PM2.5 lags showed inverse associations with 
HRV measures, and the associations were gen-
erally strongest for the 2-day moving average, 
especially for SDNN. Model 1 included age, 
sex, race/ethnicity, smoking status, BMI, fasting 
blood glucose, mean arterial pressure, serum 
triglyceride, cardiac medications, indicator of 
warm months, and regression splines of appar-
ent temperature (3 df) as covariates. Model 2 
added interaction terms between study sites 
and regression splines of apparent temperature 
Table 1. Demographic and clinical characteristics of the study population with complete data, MESA 
2000–2002.
MetS
Characteristic
Total  
(n = 5,465)
No 
(n = 3,698)
Yes 
(n = 1,767)
Age (years) 62.2 ± 10.9 61.5 ± 10.2 63.5 ± 9.8
Percent female 53.2 51.0 57.8
Race/ethnicity (%)
African American 26.6 26.8 26.0
Caucasian 38.9 40.4 35.8
Chinese 12.4 13.7 9.6
Hispanic 22.2 19.1 28.6
Education (%)
≤ High school diploma 34.9 31.2 42.5
Some college 28.8 28.1 30.2
≥ 4-year college 36.3 40.6 27.3
Study site (%)
Baltimore 14.7 14.7 14.8
Chicago 18.1 20.4 13.1
Forsyth County 15.6 14.9 17.0
Los Angeles 19.8 19.2 21.0
New York 16.1 16.6 15.0
St. Paul 15.8 14.2 19.1
Smoking status (%)
Never 51.0 51.1 50.9
Former 36.6 36.8 36.1
Current 12.4 12.1 13.0
Hypertension (%) 43.4 32.3 66.8
Diabetes (%) 11.8 3.8 28.6
Abdominal obesity (%) 53.7 38.6 85.2
Dyslipidemia (%) 18.7 3.8 49.8
Use of hypertension medication (%) 35.9 25.6 57.5
Beta blockers (%) 8.5 5.6 14.4
Ca2+ channel blockers (%) 11.7 8.8 17.7
ACE inhibitors (%) 11.3 6.7 20.8
BMI (kg/m2) 28.3 ± 5.4 27.0 ± 4.9 31.1 ± 5.2
Waist circumference (cm) 97.9 ± 14.2 94.0 ± 13.3 106.0 ± 12.5
Fasting glucose (mg/dL) 96.5 ± 28.5 89.9 ± 17.6 110.4 ± 39.7
Mean arterial pressure (mmHg) 89.8 ± 12.3 88.2 ± 12.1 93.2 ± 12.1
HDL (mg/dL) 51.0 ± 14.8 54.9 ± 14.9 42.8 ± 10.5
Triglyceride (mg/dL) 131.9 ± 88.3 105.6 ± 58.2 186.8 ± 112.1
Heart rate (beats/min) 63.0 ± 9.4 62.0 ± 9.0 65.1 ± 10.0
HRV, GM (GSD)
SDNN (msec) 18.8 (1.84) 19.5 (1.81) 17.4 (1.91)
rMSSD (msec2) 20.9 (1.96) 21.7 (1.91) 19.4 (2.04)
Environmental variables, [prior 2 days, median (IQR)]
PM2.5 (µg/m3) 14.3 (10.2–20.4) 14.4 (10.2–20.4) 14.0 (10.1–20.4)
NO2 (ppb) 23.5 (15.8–31.5) 23.9 (16.5–31.9) 22.6 (15.3–30.9)
SO2 (ppb) 3.6 (1.8–6.6) 3.7 (1.8–6.8) 3.3 (1.6–6.1)
CO (ppm) 0.90 (0.65–1.35) 0.90 (0.70–1.35) 0.90 (0.65–1.30)
Apparent temperature (°C) 11.5 (3.5–17.5) 11.3 (3.1–17.5) 11.6 (4.0–17.3)
Abbreviations: GM, geometric mean; GSD, geometric standard deviation. Unless otherwise noted, values are reported 
as mean ± SD. PM2.5, metabolic syndrome, and HRV
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along with main terms for sites and apparent 
temperature. This additional adjustment for 
site-specific apparent temperature made the 
associations slightly stronger for shorter mov-
ing averages of PM2.5 (1-day previous and 
2-day and 7-day averages), whereas the associa-
tions with longer moving averages (30-day and 
60-day averages) became weaker after such an 
adjustment. In Model 2, one IQR increment in 
2-day average of PM2.5 (10.2 µg/m3) was asso-
ciated with decreases of 1.84% (95% CI, –3.73 
to 0.08) and 2.10% (95% CI, 0.0 to 4.17) in 
SDNN and rMSSD, respectively. Associations 
became stronger after adjustment for gaseous 
co  pollutants in all lag models (Model 3), with 
more pronounced changes noted when NO2 
or CO were added to models (data not shown). 
There were no significant associations of HRV 
with gaseous pollutants (data not shown).
We conducted regression analyses for the 
2-day moving average stratified by study site 
and controlled for covariates used in Model 
1 to check heterogeneity of site-specific asso-
ciations. No significant heterogeneity of site-
specific associations was found (p-values for 
heterogeneity = 0.27 for SDNN and 0.11 
for rMSSD). Overall associations from the 
meta-analysis were –1.83% (95% CI, –3.71 
to 0.08) for SDNN and –2.03% (95% CI, 
–4.08 to 0.07) for rMSSD (data not shown).
Figure 1 shows results for effect modifica-
tion by MetS and its individual components 
in association between HRV and 2-day aver-
age of PM2.5. We found statistically signifi-
cant effect modification by MetS. One IQR 
increase in 2-day PM2.5 was significantly 
associated with 5.16% (95% CI, 2.13–8.10) 
and 6.16% (95% CI, 2.85–9.35) decreases in 
SDNN and rMSSD, respectively, among per-
sons with MetS, whereas no relationship was 
found among persons without MetS (p-values 
for interaction = 0.011 for SDNN and 0.005 
for rMSSD). We also found significant asso-
ciations of PM2.5 and rMSSD among persons 
with abdominal obesity, diabetes, or hyper-
tension, but no significant associations were 
observed among persons without those condi-
tions. The interaction terms between PM2.5 
and each individual component of MetS in 
each model were not statistically significant. 
We also examined effect modification by sex, 
education, cigarette smoking, cardiac medica-
tion (beta blockers, angiotensin-converting 
enzyme inhibitors, and calcium channel block-
ers), and statin use, but no significant effect 
modification was observed (data not shown).
Discussion
This cross-sectional, multiethnic, multicity 
study showed that exposure to greater levels 
of fine particles averaged for 2 days before 
the HRV measurement was associated with 
less HRV, as indicated by lower short-term 
recorded SDNN and rMSSD, markers of rest-
ing parasympathetic (vagal) variation of the 
Table 2. Adjusted HRV for sex, race/ethnicity, and study sites by MetS, MESA, 2000–2002.
MetS
No (n = 3,698) Yes (n = 1,767)
Characteristic n SDNN, msec rMSSD, msec n SDNN, msec rMSSD, msec
Sex
Women 1,884 19.47 (1.01) 22.54 (1.02) 1,022 17.90 (1.02) 20.33 (1.02)
Men 1,814 18.99 (1.01) 20.76 (1.02) 745 16.63 (1.03) 18.16 (1.03)
Race/ethnicity
African American 991 22.16 (1.02) 26.14 (1.02) 460 20.05 (1.03) 23.72 (1.04)
Caucasian 1,494 19.32 (1.02) 20.28 (1.02) 632 17.10 (1.03) 18.04 (1.03)
Chinese 505 17.19 (1.03) 19.56 (1.03) 170 15.87 (1.06 17.93 (1.06
Hispanic 708 18.57 (1.02) 21.12 (1.03) 505 16.29 (1.03) 17.76 (1.04)
Study site
Baltimore 542 18.14 (1.03) 20.41 (1.03) 262 18.62 (1.05) 20.78 (1.05)
Chicago 755 18.14 (1.02) 20.31 (1.02) 232 17.35 (1.04) 18.41 (1.05)
Forsyth County 551 20.54 (1.03) 22.18 (1.03) 300 18.04 (1.04) 19.88 (1.05)
Los Angeles 709 20.10 (1.02) 22.49 (1.02) 371 15.78 (1.04) 17.53 (1.04)
New York 615 18.54 (1.02) 21.30 (1.03) 265 17.17 (1.04) 19.53 (1.05)
St. Paul 526 20.08 (1.03) 23.28 (1.03) 337 16.72 (1.04) 19.33 (1.04)
Measures were log transformed for analysis and then exponentiated. Values are geometric means (geometric standard 
errors) adjusted for age and for the other two variables in the table.
Table 3. Adjusted percent change (95% CI) in HRV measures for an IQR increase in PM2.5 in models with 
various lagged exposure measures, MESA 2000–2002.
SDNN rMSSD
Model Percent change (95% CI) p-Value Percent change (95% CI) p-Value
1-day previous (IQR = 11.45 µg/m3)
Model 1 –1.18 (–2.92 to 0.59) 0.19 –1.67 (–3.57 to 0.26) 0.09
Model 2 –1.49 (–3.35 to 0.40) 0.12 –1.82 (–3.85 to 0.25) 0.08
Model 3 –1.67 (–3.77 to 0.47) 0.13 –2.02 (–4.32 to 0.32) 0.09
2-day moving average (IQR = 10.20 µg/m3)
Model 1 –1.57 (–3.32 to 0.20) 0.08 –1.99 (–3.89 to –0.05) 0.04
Model 2 –1.84 (–3.73 to 0.08) 0.06 –2.10 (–4.17 to 0.00) 0.05
Model 3 –2.25 (–4.38 to –0.08) 0.04 –2.61 (–4.93 to –0.23) 0.03
7-day moving average (IQR = 7.66 µg/m3)
Model 1 –0.53 (–2.32 to 1.29) 0.56 –1.04 (–2.99 to 0.95) 0.30
Model 2 –0.74 (–2.80 to 1.36) 0.49 –1.19 (–3.43 to 1.11) 0.31
Model 3 –0.83 (–3.17 to 1.57) 0.50 –1.49 (–4.04 to 1.12) 0.26
30-day moving average (IQR = 6.18 µg/m3)
Model 1 –1.10 (–3.19 to 1.05) 0.31 –2.14 (–4.41 to 0.19) 0.07
Model 2 –0.69 (–3.57 to 2.28) 0.64 –1.77 (–4.90 to 1.46) 0.28
Model 3 –1.90 (–5.28 to 1.61) 0.28 –3.72 (–7.36 to 0.07) 0.05
60-day moving average (IQR = 5.32 µg/m3)
Model 1 –0.87 (–3.04 to 1.36) 0.44 –1.79 (–4.16 to 0.64) 0.15
Model 2 –0.25 (–3.56 to 3.18) 0.89 –1.09 (–4.70 to 2.65) 0.56
Model 3 –1.81 (–5.80 to 2.35) 0.39 –3.74 (–8.03 to 0.76) 0.10
Model 1 adjusted for age, sex, race/ethnicity, smoking status, BMI, fasting glucose, mean arterial pressure, serum tri­
glyceride, use of beta blockers, use of Ca2+ channel blockers, use of ACE inhibitors, season (warm vs. cold season), and 
regression splines (3 df) for moving averages of apparent temperature corresponding for the predictor. Model 2 includes 
Model 1 plus interactions between study sites and regression splines (3 df) for moving averages of apparent tempera­
ture corresponding for the predictor. Model 3 includes Model 2 plus gaseous copollutants (NO2, SO2, CO).
Figure 1. Adjusted percent changes and 95% CIs in 
HRV measures for an IQR increase in PM2.5 (10.2 µg/
m3) by MetS and its components (abdominal obesity, 
diabetes, hypertension, and dys  lipidemia), MESA, 
2000–2002. The adjusted covariates are the same as 
in Model 2, Table 3, except for the covariates that 
are part of each effect modifier: The model for MetS 
did not include BMI, fasting glucose, mean arterial 
pressure (MAP), serum tri  glyceride, and cardiac 
medications (beta blockers, calcium channel block­
ers, ACE inhibitors); the model for abdominal obesity 
did not include BMI; the model for diabetes did not 
include fasting glucose; the model for hypertension 
did not include mean arterial pressure and cardiac 
medications; and the model for dyslipidemia did not 
include serum triglyceride.
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heart. Individuals with MetS had significantly 
larger decreases in HRV measures in relation 
to PM2.5 than did those without MetS. The 
associations were also consistently stronger 
among persons with individual components 
of MetS (such as abdominal obesity, diabetes, 
hypertension, or dyslipidemia) than among 
persons without the components, although 
the differences were not statistically significant. 
These findings suggest that possible cardiovas-
cular effects of PM2.5 may be mediated, in part, 
through altered autonomic function, particu-
larly among persons with MetS. The observed 
associations did not differ by sex, race/ethnicity,   
study site, educational attainment, smoking 
status, and use of antihypertension and anti-
cholesterol medications. These results were 
independent of individual-level confounders as 
well as other environmental factors.
Our findings are consistent with the 
results from a previous community-based 
study of HRV and PM2.5, but the magnitude 
of the associations in our study is smaller. A 
study conducted with 497 elderly men from 
the Normative Aging Study (NAS) found that 
the association of HRV was strongest with the 
2-day (48-hr) average of PM2.5 (Park et al. 
2005). In the present study, we modeled the 
same covariates used in the NAS to facilitate 
comparisons between the studies. In the NAS 
population, 8 µg/m3 of PM2.5 was associated 
with a 5.4% (95% CI, –1.5 to 11.8) decrease 
in SDNN, which is approximately three times 
larger than the magnitude of the association 
in our study. NAS participants with hyper-
tension or diabetes were also more susceptible 
to PM2.5 exposure than were the participants 
without these conditions. Other population-
based studies have examined PM10 rather than 
PM2.5. Liao and colleagues examined 4,899 
middle-aged and elderly participants from the 
Atherosclerosis Risk in Communities Study 
and found that 11.5 µg/m3 of PM10   measured 
1-day before was associated with a 1.03-msec 
(SE = 0.31) reduction in SDNN, which is 
equivalent to a 2.75% (95% CI, 1.13–4.37) 
decrease (based on the population mean of 
SDNN = 37.5 msec) (Liao et al. 2004). They 
also found a stronger association among per-
sons with hypertension.
Our study supports previous evidence 
that preexisting cardiometabolic diseases may 
confer susceptibility to particle-induced auto-
nomic dysfunction. Furthermore, only MetS 
was identified as a significant modifying fac-
tor, and interactions between PM2.5 and its 
individual components did not reach statistical 
significance. This suggests that a clustering of 
cardiometabolic risk factors increases suscepti-
bility to the adverse effects of particle exposure. 
MetS has been associated with diminished 
HRV among middle-aged and elderly per-
sons (Gehi et al. 2009; Liao et al. 1998; Stein 
et al. 2007) and even young adults (Koskinen 
et al. 2009). Persons with MetS are charac-
terized by central fat accumulation, insulin 
resistance, glucose intolerance, and increased 
inflammation, which are associated with an 
overactivation of the sympathetic nervous sys-
tem (Tentolouris et al. 2008). Sympathetic 
overactivity may have unfavorable impacts on 
the cardiovascular system such as development 
of hypertension, endothelial dysfunction, 
and heart failure (Tentolouris et al. 2006). It 
is unclear why and how MetS modifies the 
cardio  vascular impact of particle exposure. We 
can speculate that particle exposure worsens 
the autonomic dysfunction caused by over-
activation of the sympathetic nervous system 
because of MetS, but further toxicologic stud-
ies are needed to elucidate the biologic role of 
MetS in the association between particle expo-
sure and autonomic function.
This study was conducted in six different 
cities in the United States with a uniform 
protocol including questionnaires, physical 
measurements, and analyses of laboratory and 
ECG measurements in centralized core labora-
tories. However, different cities have samples 
with different sociodemographic characteris-
tics; they differ in meteorological conditions 
and also vary substantially in PM2.5 expo-
sures. To account for this heterogeneity, we 
not only conducted regression analyses adjust-
ing for study site and site-specific apparent 
temperature as smoothing terms, but we con-
ducted meta-analysis using site-specific regres-
sion models. The observed associations were 
similar in analyses that adjusted for site as a 
covariate and in the meta-analysis approach.
The associations between PM2.5 and HRV 
measures became much stronger after adjust-
ment for gaseous co-pollutants, especially 
NO2 and CO. Recent studies conducted in 
the United States suggest that ambient gaseous 
pollutant concentrations (such as CO and 
NO2) determined from central monitoring 
stations may not be good surrogates for cor-
responding individual-level gaseous exposures 
in epidemiologic research (Sarnat et al. 2005; 
Schwartz et al. 2007). Zeger and colleagues 
suggested that the effect estimate can be biased 
away from the true value if there is a strong 
negative correlation between measurement 
errors, because some of the effect of a more 
poorly measured variable may be transferred 
to the estimate of a better-measured variable 
(Zeger et al. 2000). Given that measurement 
errors for ambient gaseous pollutant are greater 
than those for ambient particles, adjustment 
for gaseous pollutants may lead to an over-
estimation of the true effect of particles.
Although statistically significant associa-
tions between PM2.5 and HRV measures were 
seen in this study, the magnitude of the asso-
ciations was relatively small: approximately 
2% decreases in SDNN and rMSSD with a 
10.2-µg/m3 increase in 2-day average PM2.5 
(Model 2, Table 3). These decrements were 
roughly equivalent to a cross-sectional reduc-
tion in HRV associated with about 2 years 
of aging in our sample. Given the ubiqui-
tous nature of particle exposure and the dose-
dependent relation between reduced HRV 
and incidence of cardiovascular events, even 
those small effects, if causal, have the poten-
tial to influence public health.
An important strength of our study is that 
the analysis was based on a large community 
sample that included both sexes and various 
ethnic groups and cities, with a large num-
ber of participants. However, several limita-
tions should be considered. MESA included a 
relatively healthy sample of persons without a 
prior history of CVD. If prior disease modifies 
the effects of PM on autonomic function, our 
results may not be generalizable to samples 
with preexisting cardiovascular conditions. 
However, the investigation of associations in 
large healthy samples is still of interest. The 
use of a healthy sample also minimizes resid-
ual confounding due to health conditions that 
could be related to HRV and to PM exposure, 
if persons with pre-existing conditions tend to 
live in or move to areas with greater PM expo-
sure. Additionally, we restricted the analysis to 
participants with complete values for the vari-
ables included in the regression models. This 
approach may lead to bias if the missing val-
ues are not completely random (Raghunathan 
2004). Subjects included in the analysis were 
relatively healthier than those excluded, and 
there were small differences in exclusion rates 
by sites. Although we cannot categorically rule 
out selection bias, it is unlikely that subjects 
were systematically excluded based on out-
come (i.e., HRV) and exposure data. MESA 
study sites use the same standardized proto-
cols for quality control; hence, systematic dif-
ferences in HRV measurement between sites 
or across subjects with different characteristics 
are unlikely. Although multiple imputation of 
missing data is an option, it requires a num-
ber of assumptions. Given the approach taken 
in prior MESA analyses (which have not used 
multiple imputation), we report results based 
on participants with complete data.
We assessed HRV using three consecutive 
10-sec recordings. Generally, use of records 
at least 5 min in duration is recommended 
in accordance with the previous guidelines 
(Task Force 1996). However, there has been 
interest in using ultrashort recordings, such as 
10 sec in duration, from the standard 12-lead 
ECG, because these records are much easier 
to collect in clinical and epidemiologic set-
tings (de Bruyne et al. 1999; Dekker et al. 
1997). It has been suggested that repeatability 
of HRV meas  ures from 10-sec recordings is 
high when the mean from two or three records 
is used, and correlations between the same 
measures from 10 sec and 6 min were quite PM2.5, metabolic syndrome, and HRV
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high (Schroeder et al. 2004). In our study, 
we recorded 10-sec ECGs three times and 
excluded participants with one 10-sec record. 
Because SDNN reflects overall variability of 
heart rate, which requires a fair amount of time 
to be computed (generally longer than 5 min), 
the physiologic meaning of SDNN (overall 
variability) measured for 10 sec may capture 
only part of SDNN derived from longer peri-
ods (de Bruyne et al. 1999). On the other 
hand, rMSSD reflects short-term variability 
seen with respiration at rest and is thought to 
be a marker of the parasympathetic nervous 
system variation (Task Force 1996). Therefore, 
the 10-sec SDNN and rMSSD measures used 
in this study might reflect the same phenome-
non, that is, parasympathetic modulation of 
the heart. The ultrashort records did not allow 
evaluation of frequency domain.
Another limitation is single measurement 
of HRV because of the cross-sectional design, 
which cannot rule out residual confounding 
by subject-specific characteristics. Previous 
studies from the NAS showed consistent find-
ings in both cross-sectional (Park et al. 2005) 
and longitudinal designs (Baccarelli et al. 
2008), and the magnitude of the associations 
did not change. Nevertheless, the future avail-
ability of repeated HRV measurements in this 
sample will allow analysis that relates with-
in-person changes in HRV to within-person 
changes in exposures, thus tightly accounting 
for subject-specific confounders.
Like many other population-based air pol-
lution studies, we did not measure person-level 
pollution exposure. We used PM2.5 exposure 
from the monitor nearest each participant’s 
residence. This method is likely an improve-
ment over using a single representative moni-
tor located in the center of a city. In MESA, 
38% of participants were not employed at the 
time of the survey (retired and not working, 
unemployed, or homemakers), and more than 
75% reported spending 60% of their time 
either in their home or within 1 mile (1.6 km) 
of their home. This suggests that the exposure 
assignment based on participant’s residence 
used in this study is reasonable. Nevertheless, 
we cannot exclude a possibility of exposure 
misclassification; however, such an error is 
likely to be nondifferential.
In summary, short-term exposure to PM2.5 
was marginally significantly associated with car-
diac autonomic dysfunction, as manifested by 
decreased HRV measures in a large, multicity, 
multi-ethnic, population-based sample. In addi-
tion, persons with MetS showed a larger reduc-
tion in HRV associated with PM exposures, 
suggesting MetS as a susceptibility factor to 
particle-induced autonomic dysfunction. Given 
the potential limitations, these results must be 
interpreted with caution. Our findings support 
the hypothesis that alterations in cardiac auto-
nomic function may be one of the underlying 
mechanisms through which particulate air pol-
lution increases the risk of CVD. The biologic 
role of MetS in enhancing susceptibility to par-
ticle toxicity remains to be determined.
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